Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma.

Br J Cancer · 2013 · PMC3833210 · PMID 24136145

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Skindex Emotions, Symptoms and Functioning scales showed a significant improvement from baseline, although improved EORTC QLQ-C30 Functional scales and Global Health Status results did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.